AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine, ahead of an early trial readout as soon as June or July.
There is a growing body of evidence that already-approved IL-6 could be used as treatments for COVID-19 following newly published clinical trial data – but the jury is out on whether they c
China’s Shanghai Green Valley Pharmaceuticals has clearance to begin a late stage clinical trial to support a US filing of its potential Alzheimer’s drug.